Evidence map›Paper›PMID 33000911›Full record

ArticleJournal of the International AIDS Society2020

The feasibility of recruiting and retaining men who have sex with men and transgender women in a multinational prospective HIV prevention research cohort study in sub-Saharan Africa (HPTN 075).

Theodorus Gm Sandfort, Erica L Hamilton, Anita Marais, Xu Guo, Jeremy Sugarman, Ying Q Chen, Vanessa Cummings, Sufia Dadabhai, Karen Dominguez, Ravindre Panchia and 14 more

Abstract read
In one paragraph

Article in Journal of the International AIDS Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Self-Testing as a Hope to Reduce HIV in Transgender Women-Literature Review.International journal of environmental research and public health · 2022
    Review
  16. Article
  17. Article
  18. Uptake of antiretroviral treatment and viral suppression among men who have sex with men and transgender women in sub-Saharan Africa in an observational cohort study: HPTN 075.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Theodorus Gm SandfortHIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Columbia University, New York, NY, USA.ORCID 0000-0002-4986-1739
Erica L HamiltonScience Facilitation Department, FHI 360, Durham, NC, USA.ORCID 0000-0003-1174-9263
Anita MaraisPerinatal HIV Research Unit, University of the Witwatersrand, Soweto HPTN CRS, Soweto, South Africa.
Xu GuoVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Jeremy SugarmanBerman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, USA.ORCID 0000-0001-7022-8332
Ying Q ChenVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Vanessa CummingsDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Sufia DadabhaiDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Blantyre, Malawi.
Karen DominguezDesmond Tutu HIV Centre, UCT Medical School, Cape Town, South Africa.
Ravindre PanchiaPerinatal HIV Research Unit, University of the Witwatersrand, Soweto HPTN CRS, Soweto, South Africa.
David SchnabelKenya Medical Research Institute (KEMRI) CDC, Kisumu, Kenya.
Fatima ZuluDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Blantyre, Malawi.
Doerieyah ReynoldsDesmond Tutu HIV Centre, UCT Medical School, Cape Town, South Africa.
Oscar RadebeAnova Health Institute, Johannesburg, South Africa.
Calvin MbedaKenya Medical Research Institute (KEMRI) CDC, Kisumu, Kenya.ORCID 0000-0001-8139-5160
Dunker KambaCentre for the Development of People (CEDEP), Blantyre, Malawi.
Brian KanyembaDesmond Tutu HIV Centre, UCT Medical School, Cape Town, South Africa.
Arthur OgendoKenya Medical Research Institute (KEMRI) CDC, Kisumu, Kenya.
Michael StirrattDivision of AIDS Research, National Institute of Mental Health, Bethesda, MD, USA.
Wairimu ChegeDivision of AID, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA.
Jonathan LucasScience Facilitation Department, FHI 360, Durham, NC, USA.
Maria FawzyFHI 360, Durham, NC, USA.
Laura A McKinstryVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Susan H EshlemanDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-4587-791X

Funding

LOC: HIV Prevention Trials NetworkUM1AI068619 · NIAID · FAMILY HEALTH INTERNATIONAL · PI Sinead Delany-Moretlwe, RAPHAEL J LANDOVITZ · 2011 to 2026
$779.5M
SDMC: HPTN 084 Pregnancy SupplementUM1AI068617 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Elizabeth Renata Brown, Deborah J Donnell · 2011 to 2026
$204.9M
LC: HIV Prevention Trials Network - Laboratory Support for the SARS-CoV-2 Seroprevalence Study (CoVPN 5002)UM1AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SUSAN H ESHLEMAN, Mark A Marzinke · 2011 to 2026
$100.2M
The Statistics, Data Science, and Data Management (SDM) CoreP30MH043520 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI Claude Ann Mellins · 2003 to 2026
$48.2M
Emory HIV/AIDS Clinical Trials UnitUM1AI069418 · NIAID · EMORY UNIVERSITY · PI Moises Arturo Huaman Joo, Colleen F Kelley · 2012 to 2026
$46.0M
The Malawi Clinical Trials UnitUM1AI069518 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JACKY M JENNINGS, TAHA E TAHA · 2012 to 2026
$43.8M
Neuro HPA Project 1U54AG062334 · NIA · EMORY UNIVERSITY · PI Cecile Delille Lahiri, Vasiliki Michopoulos · 2018 to 2026
$12.2M
NIAID NIH HHS UM1 AI068613NIAID NIH HHS UM1AI068613NIAID NIH HHS UM1 AI068617NIAID NIH HHS UM1AI068617NIAID NIH HHS UM1 AI068619NIAID NIH HHS UM1AI068619NIAID NIH HHS UM1 AI069418NIAID NIH HHS UM1 AI069518NIA NIH HHS U54 AG062334NIMH NIH HHS P30 MH043520NIMH NIH HHS P30 MH43520
6 · The paper itself

Abstract

introductionMen who have sex with men (MSM) and transgender women (TGW) in sub-Saharan Africa (SSA) are profoundly affected by HIV with high HIV prevalence and incidence. This population also faces strong social stigma and legal barriers, potentially impeding participation in research. To date, few multi-country longitudinal HIV research studies with MSM/TGW have been conducted in SSA. Primary objective of the HIV Prevention Trials Network (HPTN) 075 study was to assess feasibility of recruiting and retaining a multinational prospective cohort of MSM/TGW in SSA for HIV prevention research.

methodsHPTN 075, conducted from 2015 to 2017, was designed to enroll 400 MSM/TGW at four sites in SSA (100 per site: Kisumu, Kenya; Blantyre, Malawi; Cape Town, South Africa; and Soweto, South Africa). The number of HIV-positive persons was capped at 20 per site; HIV-positive persons already in care were excluded from participation. The one-year study included five biobehavioural assessments. Community-based input and risk mitigation protocols were included in study design and conduct.

resultsOf 624 persons screened, 401 were enrolled. One in five participants was classified as transgender. Main reasons for ineligibility included: (a) being HIV positive after the cap was reached (29.6%); (b) not reporting anal intercourse with a man in the preceding three months (20.6%); and (c) being HIV positive and already in care (17.5%). Five (1.2%) participants died during the study (unrelated to study participation). 92.9% of the eligible participants (368/396) completed the final study visit and 86.1% participated in all visits. The main, overlapping reasons for early termination included being (a) unable to adhere to the visit schedule, predominantly because of relocation (46.4%), and (b) unable to contact the participant (32.1%). Participants reported strong motivation to participate and few participation barriers. Four participants reported social harms (loss of confidentiality and sexual harassment by study staff) that were successfully addressed.

conclusionsHPTN 075 successfully enrolled a multinational sample of MSM/TGW in SSA in a prospective HIV prevention research study with a high retention rate and few documented social harms. This supports the feasibility of conducting large-scale research trials in this population to address its urgent, unmet HIV prevention needs.

Indexed as

Homosexuality, MalePatient Acceptance of Health CarePatient SelectionSexual and Gender MinoritiesTransgender PersonsAdolescentAdultAfrica South of the SaharaCohort StudiesFeasibility StudiesFemaleHIV InfectionsHumansMalawiMaleProspective Studiesclosed cohort studyHIVmen who have sex with mensub-Saharan Africatransgender women

Identifiers

PMID33000911
PMCPMC7527761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.